Adastra Holdings Announces Resignation of CFO, and Corporate Secretary

Langley, British Columbia–(Newsfile Corp. – October 8, 2024) – Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E) (“Adastra” or the “Company“), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, today announces that Lachlan McLeod, Chief Financial Officer and Corporate Secretary, has resigned from his roles, effective October 5th.

Mr. McLeod’s resignation as CFO and Corporate Secretary will be effective immediately. The Company is in the process of selecting and approving new candidates to fill these roles to ensure a smooth transition and maintain continuity.

About Adastra Holdings Ltd.

Adastra has become one of Canada’s leaders in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. It serves medical markets and engages in forward-looking therapeutic applications. With cannabis concentrate products sold through retailers at more than 2,000 locations across Canada, Adastra’s Phyto Extractions and Endgame Extracts brands are now well established with a growing distribution presence. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. Adastra partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market, with the ultimate aim of addressing the needs of patients. For more information, visit: www.adastraholdings.ca.